Delivery Order SPE2DB24D2010-SPE2DB25FAATT
- Not listed
- The Defense Logistics Agency awarded a $20,371.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $83,196.81 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on August 11, 2025, represents a non-set-aside competitive award and is expected to reach completion by August 12, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $14,110.96 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price, non-set-aside delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $8,815.75 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with ultimate completion by August 13, 2025, represents a single procurement under the company's larger indefinite delivery contract with DLA. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $17,970.20 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $19,913.55 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under a firm fixed price contract type. The contract involves no set-aside designation, indicating it was awarded through open competition. Performance will be executed at...
- The Defense Logistics Agency awarded a delivery order valued at $17,846.50 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $17,488.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside delivery order is scheduled for ultimate completion on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a delivery order valued at $24,594.08 to AmerisourceBergen Drug Corp for the supply of Orencia Clickject 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contractor will fulfill this order from its corporate office location in...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAATTDelivery Order
The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this delivery order from its corporate office location. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, supporting organizations including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains, positioning it as a critical vendor for military and federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.5k | 8/11/25 |